+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Letrozole"

From
From
United States KISQALI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States KISQALI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
IBRANCE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IBRANCE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Letrozole is a type of breast cancer drug used to treat postmenopausal women with hormone receptor-positive, early-stage breast cancer. It is a type of aromatase inhibitor, which works by blocking the production of estrogen in the body. This helps to slow or stop the growth of certain types of breast cancer cells that need estrogen to grow. Letrozole is usually taken once a day, with or without food. Common side effects include hot flashes, joint pain, and nausea. Letrozole is a widely used breast cancer drug, and is often prescribed in combination with other treatments such as radiation or chemotherapy. It is also used to reduce the risk of breast cancer recurrence in postmenopausal women who have already been treated with other medications. Some companies in the Letrozole market include Novartis, Pfizer, and AstraZeneca. Show Less Read more